Henan Jinyuan Hydrogenated Chemicals Co., Ltd. (HKG:2502)
Hong Kong
· Delayed Price · Currency is HKD 0.580
+0.020 (3.57%)
Mar 10, 2026, 1:34 PM HKT
HKG:2502 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Revenue | 2,942 | 3,102 | 2,330 | 2,255 | 1,480 | 1,079 |
| Revenue Growth (YoY) | 3.01% | 33.12% | 3.36% | 52.38% | 37.10% | - |
| Cost of Revenue | 2,920 | 3,030 | 2,181 | 1,967 | 1,326 | 978.11 |
| Gross Profit | 22.36 | 71.64 | 148.8 | 287.68 | 153.12 | 101.13 |
| Selling, General & Admin | 59.63 | 61.21 | 49.74 | 46.93 | 31.57 | 30.4 |
| Other Operating Expenses | 10.36 | 10.36 | 4.22 | 5.53 | 11.68 | 4.54 |
| Operating Expenses | 69.98 | 71.57 | 53.96 | 52.46 | 43.25 | 34.94 |
| Operating Income | -47.63 | 0.07 | 94.84 | 235.22 | 109.86 | 66.18 |
| Interest Expense | -16.32 | -16.47 | -6.06 | -8.02 | -2.65 | -8.56 |
| Interest & Investment Income | 5.45 | 10.53 | 5.2 | 3.73 | 3.68 | 3.76 |
| Earnings From Equity Investments | -1.16 | 0.39 | 3.15 | - | - | - |
| Currency Exchange Gain (Loss) | 0.48 | 5.47 | -0.1 | - | - | - |
| Other Non Operating Income (Expenses) | 6.16 | 11.09 | 1.94 | 2.63 | - | - |
| EBT Excluding Unusual Items | -53 | 11.07 | 98.96 | 233.55 | 110.9 | 61.39 |
| Gain (Loss) on Sale of Assets | -0.66 | 0.94 | -0.07 | - | 0.01 | - |
| Asset Writedown | - | - | - | -0 | - | - |
| Pretax Income | -53.67 | 12.01 | 98.89 | 233.55 | 110.91 | 61.39 |
| Income Tax Expense | -11.02 | 0.47 | 16.57 | 39.47 | 31.43 | 16.75 |
| Earnings From Continuing Operations | -42.65 | 11.54 | 82.32 | 194.08 | 79.48 | 44.63 |
| Minority Interest in Earnings | -23.86 | -27.58 | -27.4 | -55.85 | -7.01 | -15.54 |
| Net Income | -66.5 | -16.04 | 54.93 | 138.23 | 72.47 | 29.09 |
| Net Income to Common | -66.5 | -16.04 | 54.93 | 138.23 | 72.47 | 29.09 |
| Net Income Growth | - | - | -60.27% | 90.74% | 149.10% | - |
| Shares Outstanding (Basic) | 956 | 956 | 612 | 536 | - | - |
| Shares Outstanding (Diluted) | 956 | 956 | 612 | 536 | - | - |
| Shares Change (YoY) | 16.29% | 56.15% | 14.17% | - | - | - |
| EPS (Basic) | -0.07 | -0.02 | 0.09 | 0.26 | - | - |
| EPS (Diluted) | -0.07 | -0.02 | 0.09 | 0.26 | - | - |
| EPS Growth | - | - | -65.20% | - | - | - |
| Free Cash Flow | -19.9 | 13.82 | -43.95 | 200.43 | 67.16 | 1.62 |
| Free Cash Flow Per Share | -0.02 | 0.01 | -0.07 | 0.37 | - | - |
| Dividend Per Share | - | - | 0.020 | - | - | - |
| Gross Margin | 0.76% | 2.31% | 6.39% | 12.76% | 10.35% | 9.37% |
| Operating Margin | -1.62% | 0.00% | 4.07% | 10.43% | 7.42% | 6.13% |
| Profit Margin | -2.26% | -0.52% | 2.36% | 6.13% | 4.90% | 2.70% |
| Free Cash Flow Margin | -0.68% | 0.45% | -1.89% | 8.89% | 4.54% | 0.15% |
| EBITDA | 29.36 | 77.03 | 150.51 | 294.84 | 168.5 | 115.65 |
| EBITDA Margin | 1.00% | 2.48% | 6.46% | 13.08% | 11.39% | 10.72% |
| D&A For EBITDA | 76.99 | 76.96 | 55.67 | 59.62 | 58.63 | 49.46 |
| EBIT | -47.63 | 0.07 | 94.84 | 235.22 | 109.86 | 66.18 |
| EBIT Margin | -1.62% | 0.00% | 4.07% | 10.43% | 7.42% | 6.13% |
| Effective Tax Rate | - | 3.91% | 16.75% | 16.90% | 28.34% | 27.29% |
| Advertising Expenses | - | - | - | - | 1.29 | 1.77 |
Source: S&P Capital IQ. Standard template. Financial Sources.